Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 7, 2014; 20(41): 15135-15143
Published online Nov 7, 2014. doi: 10.3748/wjg.v20.i41.15135
Laparoscopic revolution in bariatric surgery
Magnus Sundbom
Magnus Sundbom, Department of Surgical Sciences, Uppsala University, SE-751 85 Uppsala, Sweden
Author contributions: Sundbom M solely contributed to this paper.
Correspondence to: Magnus Sundbom, MD, PhD, Department of Surgical Sciences, Uppsala University, SE-751 85 Uppsala, Sweden. magnus.sundbom@surgsci.uu.se
Telephone: +46-18-6110000 Fax: +46-18-586860
Received: November 27, 2013
Revised: April 8, 2014
Accepted: May 25, 2014
Published online: November 7, 2014

Abstract

The history of bariatric surgery is investigational. Dedicated surgeons have continuously sought for an ideal procedure to relieve morbidly obese patients from their burden of comorbid conditions, reduced life expectancy and low quality of life. The ideal procedure must have low complication risk, both in short- and long term, as well as minimal impact on daily life. The revolution of laparoscopic techniques in bariatric surgery is described in this summary. Advances in minimal invasive techniques have contributed to reduced operative time, length of stay, and complications. The development in bariatric surgery has been exceptional, resulting in a dramatic increase of the number of procedures performed world wide during the last decades. Although, a complex bariatric procedure can be performed with operative mortality no greater than cholecystectomy, specific procedure-related complications and other drawbacks must be taken into account. The evolution of laparoscopy will be the legacy of the 21st century and at present, day-care surgery and further reduction of the operative trauma is in focus. The impressive effects on comorbid conditions have prompted the adoption of minimal invasive bariatric procedures into the field of metabolic surgery.

Key Words: Laparoscopy, Bariatric surgery, Minimal invasive surgery, Gastric bypass, Duodenal switch, Gastric banding, Metabolic surgery

Core tip: Dedicated surgeons have continuously sought for an ideal procedure to relieve morbidly obese patients from their burden of comorbid conditions, reduced life expectancy and low quality of life. The ideal procedure must have low complication risk, both in short- and long-term. Advances in minimal invasive techniques have contributed to reduced operative time, length of stay, and complications. The development in bariatric surgery has been exceptional. The evolution of laparoscopy will be the legacy of the 21st century and at present, day-care surgery and further reduction of the operative trauma is in focus.



INTRODUCTION
Obesity

At present, obesity is spreading like an epidemic. The continuous improvements in public health we have been accustomed to have come to a halt, impeded by obesity. For the first time, the life span of the next generation is predicted to be shorter than their parents. Morbidly obese patients (body mass index, BMI > 40 kg/m2) are disadvantaged in our society. Not only are they afflicted by conditions associated with morbid obesity, i.e., diabetes, sleep apnoea, and cardiovascular diseases, but also forced to struggle with some of life’s simple activities, like sitting comfortably in a chair or walking normal distances. The world wide dilemma of obesity requires multiple actions, but for the already affected, bariatric surgery has become a valid option.

Surgical treatment of morbid obesity

In general, obese and especially morbidly obese patients are not well suited for any surgical treatment, but, at present, bariatric surgery is the only effective weight loss method for these patients in the long run. However, to reduce operative risks and to generate the best quality of life for patients, the chosen surgical strategy has to be very well selected and performed with high quality. The evolution of bariatric surgery has been investigational, and we owe appreciation to many great purveyors. Today, minimal invasive surgery is the first option for both surgeon and patient; however, the hard-earned fundamentals of open bariatric surgery must be preserved.

Evolution of open bariatric surgery

The surgical treatment of obesity was developed from observing patients losing weight after gastric or small bowel resections, and the first operation to treat obesity, an extensive resection of the small bowel, was performed by Henrikson in 1952. This, evidently totally irreversible operation, was followed by different types of bypasses on the small bowel, initially anastomosing the proximal jejunum to the colon, and then to the distal ileum. The jejuno-ileal bypass (JIB), leaving only the first 40 cm of the jejunum and the last 10 cm of the ileum, was developed by Kremen et al[1]. In 1954, their experience with JIB was submitted as the first paper on bariatric surgery to a peer-reviewed journal. For decades, a right mid-abdominal transverse incision typically indicated previous JIB surgery in a patient, just as the other classical scars after appendectomy, cholecystectomy, and caesarean section. Despite efforts to optimize these procedures, they were abandoned because of intractable side effects, i.e., diarrhoea, dehydration and hepatic cirrhosis[2].

In the 1970s, focus was switched to the stomach in achieving reduced intake of food. Ed Mason introduced his first operation; the vertical banded gastroplasty (VBG)[3,4], in which a small proximal gastric reservoir was created. The outlet to the remaining stomach was reinforced by a band. VGB resulted in about 50% loss of the patients overweight, unfortunately often in combination with vomiting and acid reflux. In addition, with time the gastric partitioning opened, allowing the patients to eat freely, which resulted in weight regain. Another procedure created by Mason in 1967, the gastric bypass (GBP)[5], was adopted in the beginning of the 1980s. In GBP, the jejunum was connected to a proximal and horizontally cut stomach pouch, thus reducing intake of food by bypassing the main part of the stomach. GBP became popular in early weight loss surgery in the United States owing to limited side effects and impressive weight loss. It is, however, important to remember that, at this time, all bariatric procedures were technically demanding to perform and the perioperative risks were high for the patients. Many personal alterations were made to overcome operative difficulties or other drawbacks, sometimes evident first several years after surgery.

The concept of malabsorption was refined by Scopinaro in 1972, developing the bileo-pancreatic diversion (BPD)[6], consisting of a horizontal gastric resection, to reduce food intake, and a shortening of the common part of small bowel, to produce malabsorption of ingested nutrients. The BPD came to make a large and long contribution in bariatric surgery. In a similar procedure, the duodenal switch (DS), described by Hess et al[7], Lagacé et al[8] and Marceau et al[9] in 1980s, food intake was restricted by vertical sleeve gastrectomy along the lesser curvature. After passing the pylorus, ingested food passed directly into the distal ileum, thus reducing uptake of fat. DS is known to have a lower frequency of anastomotic ulcers and dumping. Both these malabsorptive procedures result in massive and sustained weight loss, even in patients with less dietary compliance, but require life-long follow up to monitor nutritional deficiencies. In addition, some patients suffer from diarrhoea and foul gases.

For many years, weight loss surgery was unpopular with many physicians due to the side effects seen after JIB/intestinal bypasses and the high operative mortality. Three major events changed this view. First, in 1992, the National Institutes of Health (NIH) held a consensus conference, where medical experts concluded that two procedures were safe and effective in treating morbid obesity, VBG and GBP. Criteria were set to qualify for bariatric surgery, in short, being 100 pounds overweight or having a BMI above of 40 or > 35 in combination with comorbidities, with a long history of failed weight loss[10]. This convinced an increasing number of physicians to recommend surgery for their patients suffering from obesity. Second, further acceptance was gained when Walter Pories in 1995[11] could demonstrate the high and durable effect on diabetes mellitus, in his landmark paper, “Who Would Have Thought It? An Operation Proves to be the Most Effective Treatment for Adult-onset Diabetes Mellitus”. The many following studies from the Swedish Obese Subjects (SOS) study have verified and enhanced the impressive effect on comorbid conditions. Third, the development of improved operative instruments, facilitating surgery in this difficult group of patients, reduced postoperative complications. Bariatric surgery was associated with long postoperative stay and rather high mortality, when performed with standard instruments for general surgery, requiring large incisions and long operative time. The surgical instruments routinely used today, e.g., cutting linear staplers, energy devices, and other specially designed tools, were not available.

The laparoscopic revolution

In 1994, Wittgrove et al[12] pioneered by performing the first laparoscopic GBP, after developing the technique in the laboratory. With a six-trocar technique they were able to create a 21-mm circular stapled gastrojejunostomy to a 75-cm retrocolic retrogastric Roux limb. The anvil of the circular stapler was passed transorally, using a proprietary technique. The initial results were excellent, and the authors later reported on 500 patients who maintained 73% excess body weight loss at 54 mo[13]. The leakage rate was low, 2.2%, and comparable to the open procedure at that time. The overall complication rate was less than 10%, which indicated that the laparoscopic approach was indeed feasible and safe. In Sweden, another pioneer, Lönroth, used manual suture technique to connect an antecolic jejunal loop to the proximal pouch in a small series of six patients[14]. In 2003, the Gothenburg group could report comparable long-term weight loss in the first 76 consecutive laparoscopic GBP-patients to open procedures[15]. Other authors have followed with large series of laparoscopic gastric bypass procedures with excellent results. In a well-known series of 400 patients, Higa et al[16] reported very low complication rates, and no leakages at the gastrojejunal anastomosis. They could also demonstrate maintained excess weight loss at 3 years after laparoscopy in one if the largest series at that time[17]. To shorten the learning curve, hand-assisted laparoscopy, allowing the surgeon to have a helping hand in the abdomen, was used in some centres, but neither costs, nor length of stay was favourable to total laparoscopy[18,19].

In the modern version, Roux-en-Y Gastric Bypass, a divided jejunal loop (Roux-limb) is connected to a gastric pouch, based on the lesser curvature. A small gastric pouch is believed to facilitate long-term weight-loss and reduce the frequency of anastomotic ulcers in the acid-vulnerable jejunal mucosa. The gastrojejunostomy, the most critical part of the procedure, has been performed by different techniques, circular and linear stapler, and a totally hand-sewn, all having their specific pro and cons. In short, a more manual technique, gives the surgeon improved control, but at the price of increased technical demand and operative time. Systematic reviews have concluded that linear stapling for the gastrojejunostomy will reduce the frequency of strictures, surgical wound infections and operative time[20]. The placement of the Roux limb, antecolic antegastric, retrocolic antegastric, or retrocolic retrogastric, is determined by the surgeon’s preference. Laparoscopic gastric bypass was soon proved to be feasible and safe in the surgical treatment of morbidly obese patients, and often referred to as “gold standard” in bariatric surgery.

Parallel to this, the laparoscopic approach was also adopted for VBG with early publications from Italy, United States and Sweden[21-23]. Lönroth et al[22] reported that in 38 laparoscopically operated patients, the postoperative course was characterised by less postoperative pain, earlier mobilization, and an improved respiratory function compared to patients operated on with an open VBG. A shorter and less cumbersome postoperative period was soon noted[22-24], as well as similar weight loss compared to conventionally operated patients.

In early studies by Fried et al[25,26], laparoscopic placement of fixed gastric bands resulted in less wound-associated complications and incisional hernias than an open surgery. The frequent problem with intraoperative calibration of the fixed bands[27], was solved with a brand new product, designed specifically to be inserted by minimal invasive techniques, the Adjustable Gastric Band (AGB). Pioneering work on the laparoscopic adjustable gastric band was performed in Italy, Belgium and Sweden[28-32]. In clinical practice, laparoscopic adjustable gastric banding boomed during the coming decade. However, in retrospect, reports on technical problems with slippage and pouch dilatation as well as reflux problems and disappointing long-term results[33] were soon published. The reoperation rate was later found to be high, 40%-50%[34,35] and the weight result rather poor, 30%-50% excess weight loss. In Europe, the heyday came to a stop, and laparoscopic adjustable gastric banding was abandoned in many countries, e.g., France from 84% to 25% in 2005-2011[36]. In 2001, laparoscopic adjustable gastric banding had a revival in the US, when approved by the Food and Drug Administration (FDA). Banding quickly took almost half the market in the former GBP-dominated country. The comeback was relatively short as similar results to the European were presented in the US, inferior weight loss and more long-term complications[37,38] compared to the American gold standard, laparoscopic gastric bypass.

In 1998, Ren et al[39] published the first series of laparoscopic duodenal switch, a technically demanding procedure reserved for laparoscopic experts. In 2003, the possibility of a two-stage procedure in super-super obese patients was suggested to overcome technical difficulties[40]. The idea was to first transform the stomach into a gastric sleeve, creating a 40-50 kg weight-loss, thus facilitating the later division of the duodenum and anastomosis to the ileum. However, many patients did not return for the planned second stage, satisfied by their initial weight loss, and a new stand alone procedure was born, the laparoscopic Sleeve Gastrectomy (SG). In SG, the risk for nutritional deficiencies is reduced, as patients have an intact gastrointestinal tract, except for the reduced gastric volume. The number of laparoscopic SGs have increased dramatically in the US, replacing AGB, even though some technical details under discussion, for example in reducing the frequency of postoperative reflux (Figure 1).

Figure 1
Figure 1 Landmarks for important bariatric procedures, jejuno-ileal bypass, vertical banded gastroplasty, gastric bypass, bileo-pancreatic diversion, duodenal switch, and adjustable gastric banding, including schematic drawings.
Success of laparoscopic bariatric surgery

The first years of this millennium were characterized by large and refreshing publicity on bariatric surgery in both medical and lay literature. In the end of the 1990s, several celebrities, having had laparoscopic bariatric surgery, spoke out in media and across the internet. This was in great contrast to what the pioneers had endured in prior years. Suddenly, the laparoscopic approach was accepted by the public and the number of bariatric procedures rocketed. In the US, the percentage of laparoscopic-GBP increased from 1.5% to 17.1% between 1998 and 2003[41]. In consecutive reviews, Buchwald et al[42,43] have been able to present unique world-wide data on all bariatric surgery performed in the individual nations belonging to the International Federation for the Surgery of Obesity, IFSO. The proportion of laparoscopic bariatric surgery rose from 63% in 2002-2003 to over 90% in 2008, as demonstrated in Figure 2. From nearly nothing to 90% in a decade, a truly remarkable result. Compared to other abdominal procedures, the laparoscopic technique was estimated to have surpassed open surgery for cholecystectomy in 1992, reflux surgery in 1996 and bariatric surgery in 2005, followed by appendectomy in 2006 and colectomy in 2009[44] (Table 1). The progress in bariatric surgery is impressive as laparoscopy in morbidly obese patients is technically demanding, and that the procedures in themselves are more complex, e.g., requiring stapling, handling of the small bowel and construction of anastomoses, compared to the other procedures, addressing only one organ, in addition often resected. In spite of the switch to laparoscopy, mortality in bariatric surgery has remained low or even decreased[45], and is today similar to cholecystectomy[46]. As a result, laparoscopic surgery is the natural choice for most patients and surgeons, regardless of the type of procedure.

Table 1 Evolution of laparoscopy for common procedures in general surgery.
First reported (yr)Laparoscopy > open (yr)LaparoscopyConversion to openComplicationMortalityLength of stay (d)
Cholecystectomy1989199277%15%4%0.3%2
Reflux1991199684%3%4%0.2%3
Bariatric surgery1994200594%1%2%0.1%2
Appendectomy1983200680%2%1%0.0%2
Colectomy1991200952%14%6%0.4%5
Figure 2
Figure 2 Proportion of bariatric surgery that was performed with laparoscopic approach world wide. In 2003-2008, a concurrent increase from 146000 to 340000 annual procedures was seen.

As a consequence to the remarkable development in laparoscopy, the number of bariatric procedures have increased world wide. In the above mentioned reviews by Buchwald[43], a doubling was seen in the IFSO-nations, from 146000 to 340000 procedures in 2003-2008. In the US, a ten-fold increase has been seen, reaching 200000 annual bariatric procedures, mainly performed by laparoscopy. In Europe, around 50-100 bariatric procedures are presently performed per 100000 inhabitants in many countries[47]. Worldwide 2003-2011, AGB decreased sharply with a concomitant increase in SG, from 0% to 25%, with GBP increasing slightly. No other procedure exceeded 2%-3% (Figure 3). In Europe, AGB had a large drop and for example in Sweden, laparoscopic GBP constitutes of 97% of all bariatric surgery in 2013.

Figure 3
Figure 3 Proportion of the three major bariatric procedures, gastric bypass, adjustable gastric banding, and sleeve gastrectomy, performed world wide 2003-2011. Major part, but not all are performed with laparoscopic technique. Data are adopted from Buchwald et al[42,43,47].
Advantages with laparoscopy

In general, the introduction of laparoscopy in bariatric surgery has reduced wound-related complications and improved patient recovery[48], identical to most other procedures such as laparoscopic cholecystectomy and appendectomy[49]. In addition, laparoscopy reduced the earlier high frequency of incisional hernias. Mortality was found to be lower for laparoscopic procedures than for open surgery, 0.16% and 0.41%, respectively[50]. Overall, the reduced perioperative risks and improved patient recovery after laparoscopy have been well documented and outweigh the potential procedure-related risks. Super-obese patients (BMI > 50) have, however, been associated with increased length of stay and 30-d mortality (0.26% vs 0.07%) after bariatric surgery, compared to morbidly obese, although, the overall complication rates and mortality was low[51]. As the minimal invasiveness of laparoscopic surgery has made two-stage procedures possible, super obese patients can be treated by an initial sleeve gastrectomy, and after 40-50 kg of weight loss, have the second part of a duodenal switch, without the surgeon fighting dense adhesions. Postoperative systemic inflammation is lower after laparoscopy than open surgery, with less increase in total white blood cell count as well as segmented neutrophil cells and C-reactive protein (CRP)[52]. The reduced inflammation and minimal invasiveness, makes surgeons more willing to take the patient back to the operating room and “drop in a scope”, than to reopen a large abdominal incision to check for leakage.

In a systematic review of fast-track laparoscopic bariatric surgery, next-day discharge was possible in 81%-100% after GBP[53]. These promising results led to the possibility of day-care surgery (< 23 h), an impossible idea only a decade ago. In a systematic search published in 2011[54], 84% of all intended day-care laparoscopic GBP could return home within 23 h as planned, with only 1.8% of the patients readmitted. Thanks to its minimal invasive nature and good results, laparoscopic GBP has also been used with good results in obese adolescents[55] and older patients, above 60-70 years[56].

Special demands in laparoscopy

In general, laparoscopy is a high-tech procedure requiring a thin laparoscope, 5-12 mm, with a strong light source, video processor and high-quality video screens. To obtain working space in the abdomen; a pressure-triggered gas insufflator with gas-tight trocars, however, allowing smooth passage of specially designed instruments of different diameters, is needed. Laparoscopic procedures are technically more demanding for the surgeon, because of the loss of sensation and high demand of eye-hand coordination for safe use of the intraabdominal instruments. Not only the surgeon, but the whole team needs to be familiar with the special setting. In a study by Stepaniak et al[57], working with fixed teams in laparoscopic bariatric surgery reduced duration of the procedure, improved teamwork and safety climate.

Laparoscopic surgery has some specific drawbacks. First, in entering the abdomen, a complete new problem has evolved, the blind entry of the first trocar. Injuries to the aorta and other intraabdominal organs have been described, often leading to severe complications, if not treated correctly[58]. Second, in bariatric surgery, the enlarged left liver lobe obscures the area around the gastro oesophageal junction, where the most complicated parts of the procedure is done. The overcome this, most surgeons pre-treat their patients by a 2-4 wk long preoperative low calorie diet, as this results in improved visualisation and reduced operative time[59], mainly by reducing the intrahepatic fat. Third, the most devastating complication is however, incarcerated internal hernias behind a transposed small bowel loop. When two small bowel loops are brought together, a defect will occur between the two mesenteries, and this space will enlarge during the weight loss. As the formation of adhesions is reduced compared to open surgery, the small bowel is more prone to slide into the opening. This will result in colicky pain, often aggravated after meals, prompting a CT-scan or diagnostic laparoscopy. If treated early, the entangled small bowel loops can be retracted and the defect closed, otherwise a massive gangrene can occur due to ischemia. The later patients suffer the risk of developing a short bowel syndrome, often needing revision of the bariatric operation to reduce the need for parenteral nutrition.

We cannot make significant technical changes to well-proved procedures, just to be able to perform them by laparoscopy. The technical difficulties during the initial learning curve in laparoscopic surgery led to a number of malpractice cases and increased attention by press and plaintiff attorneys, threatening the entire process. In addition, patients interested in the aesthetic advantages and enhanced recovery might not see laparoscopy as “a real operation”. To avoid misunderstandings, surgeons must take special care in preparing them for the possibility of conversion to open surgery as well as discussing potential severe short- and long-term complications. Finally, young surgeons, skilled in laparoscopy, might not be comfortable in converting a procedure into open surgery, especially in an emergency situation.

FUTURE DEVELOPMENT

Two new techniques, robotic-assisted laparoscopy and single incision laparoscopic surgery (SILS), is being developed. In robotic-assisted laparoscopy, the assistant is replaced by a high-technological mechanical device; otherwise the procedure is performed identically as in conventional laparoscopy. In two recent reviews[60,61], no clear reduction in complications or operative time could be seen. However, the learning curve could be shorter, possibly because of superior imaging and freedom of movement compared to traditional laparoscopy. In SILS, a multi-channel trocar is placed in the umbilical region, to reduce the number of trocars and improve cosmetics. Postoperative use of opiates have shown to be reduced, however, operative time is, so far, similar or longer to conventional laparoscopy[62]. Improved trocars, to increase the working space for hands and instruments around the SILS-device outside of the abdomen, are under development. The latest minimal invasive technique, natural orifice transluminal endoscopic surgery (NOTES), in which the abdominal cavity is entered through, for example, the stomach or vagina, results in total scar-free surgery. NOTES has been used in appendectomy, but also in bariatric surgery, e.g., sleeve gastrectomy[63], but is not ready for routine use.

Furthermore, the remarkable effect on metabolic diseases, in addition to massive weight loss, will bring the laparoscopic bariatric procedures into a new era. Early studies and recent randomised controlled trials by Schauer and Mingrone[64,65] have proven bariatric surgery to be superior in achieving complete remission of adult-onset diabetes, even in patients with a BMI of 30-35. This opens a large new field for surgical treatment for chronic, metabolic diseases in obese and non-obese patients, by adopting the minimal-invasive bariatric procedures, thus going beyond weight loss into metabolic surgery. The laparoscopic revolution might therefore, not only have improved quality of life and longevity for obese patients, but ultimately decrease the cost of health care. Who could have predicted this development, when the pioneering work was started in the mid of the 20th century?

CONCLUSION

Bariatric surgery has been investigational. Pioneers have continuously sought for an ideal procedure in order to relieve morbidly obese patients from their comorbid conditions, and to increase life expectancy and quality of life. The ideal procedure should also have low risk of complications, both in short- and long term, and minimal negative impact on daily life. In only a decade, laparoscopic techniques have revolutionized bariatric surgery, reducing operative time, length of stay, and risk for complications, without hampering long-term benefits. The laparoscopic revolution has also resulted in a vast increase of the number of bariatric procedures performed world-wide. At present, technical improvement of instruments and techniques for further minimizing the abdominal entry is in focus. The next revolution, adopting minimal invasive bariatric procedures as treatment for type 2 diabetes and other metabolic diseases, is about to start.

ACKNOWLEDGMENTS

The past, present, and future pioneers in bariatric surgery, for helping morbidly obese individuals to a decent life.

Footnotes

P- Reviewer: Anadol Z, Beeres M, ElGeidie AAR, Gurkan A S- Editor: Nan J L- Editor: A E- Editor: Liu XM

References
1.  Kremen AJ, Linner JH, Nelson CH. An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg. 1954;140:439-448.  [PubMed]  [DOI]
2.  Griffen WO, Bivins BA, Bell RM. The decline and fall of the jejunoileal bypass. Surg Gynecol Obstet. 1983;157:301-308.  [PubMed]  [DOI]
3.  Mason EE. Vertical banded gastroplasty for obesity. Arch Surg. 1982;117:701-706.  [PubMed]  [DOI]
4.  Mason EE, Doherty C, Cullen JJ, Scott D, Rodriguez EM, Maher JW. Vertical gastroplasty: evolution of vertical banded gastroplasty. World J Surg. 1998;22:919-924.  [PubMed]  [DOI]
5.  Mason EE, Ito C. Gastric bypass in obesity. Surg Clin North Am. 1967;47:1345-1351.  [PubMed]  [DOI]
6.  Scopinaro N. Why the Operation I Prefer is Biliopancreatic Diversion (BPD). Obes Surg. 1991;1:307-309.  [PubMed]  [DOI]
7.  Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg. 1998;8:267-282.  [PubMed]  [DOI]
8.  Lagacé M, Marceau P, Marceau S, Hould FS, Potvin M, Bourque RA, Biron S. Biliopancreatic Diversion with a New Type of Gastrectomy: Some Previous Conclusions Revisited. Obes Surg. 1995;5:411-418.  [PubMed]  [DOI]
9.  Marceau P, Hould FS, Simard S, Lebel S, Bourque RA, Potvin M, Biron S. Biliopancreatic diversion with duodenal switch. World J Surg. 1998;22:947-954.  [PubMed]  [DOI]
10.  NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115:956-961.  [PubMed]  [DOI]
11.  Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339-350; discussion 350-352.  [PubMed]  [DOI]
12.  Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic Gastric Bypass, Roux-en-Y: Preliminary Report of Five Cases. Obes Surg. 1994;4:353-357.  [PubMed]  [DOI]
13.  Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3-60 month follow-up. Obes Surg. 2000;10:233-239.  [PubMed]  [DOI]
14.  Lönroth H, Dalenbäck J, Haglind E, Lundell L. Laparoscopic gastric bypass. Another option in bariatric surgery. Surg Endosc. 1996;10:636-638.  [PubMed]  [DOI]
15.  Olbers T, Lönroth H, Fagevik-Olsén M, Lundell L. Laparoscopic gastric bypass: development of technique, respiratory function, and long-term outcome. Obes Surg. 2003;13:364-370.  [PubMed]  [DOI]
16.  Higa KD, Boone KB, Ho T, Davies OG. Laparoscopic Roux-en-Y gastric bypass for morbid obesity: technique and preliminary results of our first 400 patients. Arch Surg. 2000;135:1029-1033; discussion 1033-1034.  [PubMed]  [DOI]
17.  Higa KD, Boone KB, Ho T. Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients--what have we learned? Obes Surg. 2000;10:509-513.  [PubMed]  [DOI]
18.  Sundbom M, Gustavsson S. Randomized clinical trial of hand-assisted laparoscopic versus open Roux-en-Y gastric bypass for the treatment of morbid obesity. Br J Surg. 2004;91:418-423.  [PubMed]  [DOI]
19.  DeMaria EJ, Schweitzer MA, Kellum JM, Meador J, Wolfe L, Sugerman HJ. Hand-assisted laparoscopic gastric bypass does not improve outcome and increases costs when compared to open gastric bypass for the surgical treatment of obesity. Surg Endosc. 2002;16:1452-1455.  [PubMed]  [DOI]
20.  Giordano S, Salminen P, Biancari F, Victorzon M. Linear stapler technique may be safer than circular in gastrojejunal anastomosis for laparoscopic Roux-en-Y gastric bypass: a meta-analysis of comparative studies. Obes Surg. 2011;21:1958-1964.  [PubMed]  [DOI]
21.  Catona A, Gossenberg M, Mussini G, La Manna L E. Videolaparoscopic Vertical Banded Gastroplasty. Obes Surg. 1995;5:323-326.  [PubMed]  [DOI]
22.  Lönroth H, Dalenbäck J, Haglind E, Josefsson K, Olbe L, Fagevik Olsén M, Lundell L. Vertical banded gastroplasty by laparoscopic technique in the treatment of morbid obesity. Surg Laparosc Endosc. 1996;6:102-107.  [PubMed]  [DOI]
23.  Catona A, Gossenberg M, La Manna A G. Laparoscopic Gastric Banding: preliminary series. Obes Surg. 1993;3:207-209.  [PubMed]  [DOI]
24.  Chua TY, Mendiola RM. Laparoscopic Vertical Banded Gastroplasty: The Milwaukee Experience. Obes Surg. 1995;5:77-80.  [PubMed]  [DOI]
25.  Fried M, Peskova M. New Approach in Surgical Treatment of Morbid Obesity: Laparoscopic Gastric Banding. Obes Surg. 1995;5:74-76.  [PubMed]  [DOI]
26.  Fried M, Peskova M. Gastric Banding: Advantages and Complications. A 5- and 10-Year Follow-up. Obes Surg. 1995;5:372-374.  [PubMed]  [DOI]
27.  Broadbent R. Lessons Learned from Laparoscopic Gastric Banding. Obes Surg. 1993;3:415-420.  [PubMed]  [DOI]
28.  Morino M, Toppino M, Garrone C, Morino F. Laparoscopic adjustable silicone gastric banding for the treatment of morbid obesity. Br J Surg. 1994;81:1169-1170.  [PubMed]  [DOI]
29.  Belachew M, Legrand M, Vincenti V, Deffechereux T, Jourdan JL, Monami B, Jacquet N. Laparoscopic Placement of Adjustable Silicone Gastric Band in the Treatment of Morbid Obesity: How to Do It. Obes Surg. 1995;5:66-70.  [PubMed]  [DOI]
30.  Favretti F, Cadière GB, Segato G, Bruyns G, De Marchi F J, Belluco C, Lise M. Laparoscopic Placement of Adjustable Silicone Gastric Banding: Early Experience. Obes Surg. 1995;5:71-73.  [PubMed]  [DOI]
31.  Catona A, La Manna L, La Manna A, Sampiero C. Swedish adjustable gastric banding: a preliminary experience. Obes Surg. 1997;7:203-205; discussion 206.  [PubMed]  [DOI]
32.  Forsell P, Hellers G. The Swedish Adjustable Gastric Banding (SAGB) for morbid obesity: 9 year experience and a 4-year follow-up of patients operated with a new adjustable band. Obes Surg. 1997;7:345-351.  [PubMed]  [DOI]
33.  Morino M, Toppino M, Garrone C. Disappointing long-term results of laparoscopic adjustable silicone gastric banding. Br J Surg. 1997;84:868-869.  [PubMed]  [DOI]
34.  Angrisani L, Cutolo PP, Formisano G, Nosso G, Vitolo G. Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 10-year results of a prospective, randomized trial. Surg Obes Relat Dis. 2013;9:405-413.  [PubMed]  [DOI]
35.  Victorzon M, Tolonen P. Mean fourteen-year, 100% follow-up of laparoscopic adjustable gastric banding for morbid obesity. Surg Obes Relat Dis. 2013;9:753-757.  [PubMed]  [DOI]
36.  Lazzati A, Guy-Lachuer R, Delaunay V, Szwarcensztein K, Azoulay D. Bariatric surgery trends in France: 2005-2011. Surg Obes Relat Dis. 2014;10:328-334.  [PubMed]  [DOI]
37.  Nguyen NQ, Game P, Bessell J, Debreceni TL, Neo M, Burgstad CM, Taylor P, Wittert GA. Outcomes of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding. World J Gastroenterol. 2013;19:6035-6043.  [PubMed]  [DOI]
38.  Spivak H, Abdelmelek MF, Beltran OR, Ng AW, Kitahama S. Long-term outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in the United States. Surg Endosc. 2012;26:1909-1919.  [PubMed]  [DOI]
39.  Ren CJ, Patterson E, Gagner M. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg. 2000;10:514-523; discussion 524.  [PubMed]  [DOI]
40.  Silecchia G, Rizzello M, Casella G, Fioriti M, Soricelli E, Basso N. Two-stage laparoscopic biliopancreatic diversion with duodenal switch as treatment of high-risk super-obese patients: analysis of complications. Surg Endosc. 2009;23:1032-1037.  [PubMed]  [DOI]
41.  Encinosa WE, Bernard DM, Steiner CA. Advances in bariatric surgery for obesity: laparoscopic surgery. Adv Health Econ Health Serv Res. 2007;17:131-148.  [PubMed]  [DOI]
42.  Buchwald H, Williams SE. Bariatric surgery worldwide 2003. Obes Surg. 2004;14:1157-1164.  [PubMed]  [DOI]
43.  Buchwald H, Oien DM. Metabolic/bariatric surgery Worldwide 2008. Obes Surg. 2009;19:1605-1611.  [PubMed]  [DOI]
44.  Nguyen NT, Nguyen B, Shih A, Smith B, Hohmann S. Use of laparoscopy in general surgical operations at academic centers. Surg Obes Relat Dis. 2013;9:15-20.  [PubMed]  [DOI]
45.  Sundbom M, Karlson BM. Low mortality in bariatric surgery 1995 through 2005 in Sweden, in spite of a shift to more complex procedures. Obes Surg. 2009;19:1697-1701.  [PubMed]  [DOI]
46.  Lundell L. Principles and results of bariatric surgery. Dig Dis. 2012;30:173-177.  [PubMed]  [DOI]
47.  Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23:427-436.  [PubMed]  [DOI]
48.  Kendrick ML, Dakin GF. Surgical approaches to obesity. Mayo Clin Proc. 2006;81:S18-S24.  [PubMed]  [DOI]
49.  Woodham BL, Cox MR, Eslick GD. Evidence to support the use of laparoscopic over open appendicectomy for obese individuals: a meta-analysis. Surg Endosc. 2012;26:2566-2570.  [PubMed]  [DOI]
50.  Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142:621-632; discussion 632-635.  [PubMed]  [DOI]
51.  Kakarla VR, Nandipati K, Lalla M, Castro A, Merola S. Are laparoscopic bariatric procedures safe in superobese (BMI ≥50 kg/m2) patients? An NSQIP data analysis. Surg Obes Relat Dis. 2011;7:452-458.  [PubMed]  [DOI]
52.  Csendes A, Burgos AM, Roizblatt D, Garay C, Bezama P. Inflammatory response measured by body temperature, C-reactive protein and white blood cell count 1, 3, and 5 days after laparotomic or laparoscopic gastric bypass surgery. Obes Surg. 2009;19:890-893.  [PubMed]  [DOI]
53.  Elliott JA, Patel VM, Kirresh A, Ashrafian H, Le Roux CW, Olbers T, Athanasiou T, Zacharakis E. Fast-track laparoscopic bariatric surgery: a systematic review. Updates Surg. 2013;65:85-94.  [PubMed]  [DOI]
54.  Thomas H, Agrawal S. Systematic review of 23-hour (outpatient) stay laparoscopic gastric bypass surgery. J Laparoendosc Adv Surg Tech A. 2011;21:677-681.  [PubMed]  [DOI]
55.  Black JA, White B, Viner RM, Simmons RK. Bariatric surgery for obese children and adolescents: a systematic review and meta-analysis. Obes Rev. 2013;14:634-644.  [PubMed]  [DOI]
56.  Hazzan D, Chin EH, Steinhagen E, Kini S, Gagner M, Pomp A, Herron D. Laparoscopic bariatric surgery can be safe for treatment of morbid obesity in patients older than 60 years. Surg Obes Relat Dis. 2006;2:613-616.  [PubMed]  [DOI]
57.  Stepaniak PS, Heij C, Buise MP, Mannaerts GH, Smulders JF, Nienhuijs SW. Bariatric surgery with operating room teams that stayed fixed during the day: a multicenter study analyzing the effects on patient outcomes, teamwork and safety climate, and procedure duration. Anesth Analg. 2012;115:1384-1392.  [PubMed]  [DOI]
58.  Sundbom M, Hedberg J, Wanhainen A, Ottosson J. Aortic injuries during laparoscopic gastric bypass for morbid obesity in Sweden 2009-2010: a nationwide survey. Surg Obes Relat Dis. 2014;10:203-207.  [PubMed]  [DOI]
59.  Edholm D, Kullberg J, Haenni A, Karlsson FA, Ahlström A, Hedberg J, Ahlström H, Sundbom M. Preoperative 4-week low-calorie diet reduces liver volume and intrahepatic fat, and facilitates laparoscopic gastric bypass in morbidly obese. Obes Surg. 2011;21:345-350.  [PubMed]  [DOI]
60.  Bailey JG, Hayden JA, Davis PJ, Liu RY, Haardt D, Ellsmere J. Robotic versus laparoscopic Roux-en-Y gastric bypass (RYGB) in obese adults ages 18 to 65 years: a systematic review and economic analysis. Surg Endosc. 2014;28:414-426.  [PubMed]  [DOI]
61.  Fourman MM, Saber AA. Robotic bariatric surgery: a systematic review. Surg Obes Relat Dis. 2012;8:483-488.  [PubMed]  [DOI]
62.  Chakravartty S, Murgatroyd B, Ashton D, Patel A. Single and multiple incision laparoscopic adjustable gastric banding: a matched comparison. Obes Surg. 2012;22:1695-1700.  [PubMed]  [DOI]
63.  Ramos AC, Zundel N, Neto MG, Maalouf M. Human hybrid NOTES transvaginal sleeve gastrectomy: initial experience. Surg Obes Relat Dis. 2008;4:660-663.  [PubMed]  [DOI]
64.  Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567-1576.  [PubMed]  [DOI]
65.  Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577-1585.  [PubMed]  [DOI]